MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker.

Press/Media: Research

Period	Feb 17 2025

Media coverage

Title	MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker.
Media name/outlet	Physicians Weekly
Country/Territory	United States
Date	17/2/25
URL	ct.moreover.com/?a=56041999860&p=1gw&v=1&x=2f2El9o9PAFtO2QgOqlD8A
Persons	Yang Yang